Protocol for a double-blind placebo-controlled randomised controlled trial assessing the impact of oral semaglutide in amyloid positivity (ISAP) in community dwelling UK adults.

Ivan KoychevAmanda I AdlerPaul EdisonBrian TomJoanne E MiltonJoe ButchartAdam HampshireCharles MarshallElizabeth CoulthardHenrik ZetterbergPeter HellyerFrancesca CormackBenjamin R UnderwoodCatherine J MummeryRury R Holman

Published in: BMJ open (2024)

ISRCTN71283871.

Keyphrases

community dwelling
study protocol
placebo controlled
randomized controlled trial
double blind
cross sectional
phase ii
phase iii
open label
phase ii study
squamous cell carcinoma